. 2020 Jun 4;9(7):617–626. doi: 10.1530/EC-20-0147
This work is licensed under a Table 1.
Clinical characteristics of GO subjects.
| Sex (M/F) | Age (year) | Height (cm) | Weight (kg) | GO Duration (months) | CAS | FT3 (pmol/L) | FT4 (pmol/L) | T3 (pmol/L) | T4 (pmol/L) | TSH (uIU/mL) | TPOAb (IU/mL) | TGAb (IU/mL) | TRAb (IU/L) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Case (35) | 18/17 | 47.9±10.6 | 167.9±7.8 | 68.6±10.0 | 6 (4, 12) | 3 (2, 3) | 5.32 (4.67, 6.62) | 16.6 (13.8, 18.7) | 1.87 (1.61, 2.36) | 109 (94, 137) | 0.42 (0.03, 2.67) | 12.1 (7.5, 208) | 16.3 (10.9, 226) | 4.18 (1.22, 11.2) |
Values are expressed as n, means ± s.d., median (25th percentile, 75th percentile).
CAS, clinical activity score; TGAb, antithyroglobulin antibody; TPOAb, thyroperoxidase antibody; TRAb, thyrotrophin receptor antibody; TSH, thyroid stimulating hormone.